An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT t...
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group
Subjects
More information
Scope and Contents
Contents
Objectives To estimate the costs and benefits of clinical pathways incorporating a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinics compared with standard off-site laboratory testing. Method We simulated 1.2 million GUM clinic attendees in England. A simulation in Micros...
Alternative Titles
Full title
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3932743
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3932743
Other Identifiers
ISSN
1368-4973
E-ISSN
1472-3263
DOI
10.1136/sextrans-2013-051147
